Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment regimens using anti-NKG2A antibodies

Treatment regimens using anti-NKG2A antibodies

US Patent 10676523 · Granted Jun 9, 2020

Estimated economic value: $596,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of T cell lymphoma2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
NKp46 binding agents2025
NKp46 binding agents2025
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of 2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Treatment regimens using anti-NKG2A antibodies2024
Treatment regimens using anti-NKG2A antibodies2024
Treatment regimens using anti-NKG2A antibodies2024
Treatment regimens using anti-NKG2A antibodies2024
Treatment regimens using anti-NKG2A antibodies2024